Shares of Co-Diagnostics Inc. (CODX) are up over 79%, following news that the Company has completed the principle design work for a PCR screening test for new coronavirus, 2019-nCoV, intended to address potential need for detection of the virus.
from RTT - Biotech https://ift.tt/2TQ2QLG
via IFTTT
No comments:
Post a Comment